HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
People

Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive

Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in about 170 billion Japanese yen ($1.07 billion) in restructuring costs and some 100 billion yen ($633 million) in gross savings for 2026.

By FiercePharma · May 17, 2026 · via FiercePharma
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
PeopleFiercePharma ↗
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be head…
May 18, 2026
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
PeopleFierceBiotech ↗
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …
May 17, 2026
CDER chief Høeg fired from FDA as other top roles turn over
PeopleEndpoints News ↗
CDER chief Høeg fired from FDA as other top roles turn over
The leader of the FDA's drug division, Tracy Beth Høeg, is expected to depart, as part of a broad shakeup at t…
May 15, 2026